MSK Flashcards
(287 cards)
Define Osteoarthritis
Osteoarthritis is characterised by progressive synovial joint damage resulting in structural changes, pain and reduced function. It is the ‘wear and tear’ of joints.
Usually primary, but can be secondary to joint disease or other conditions e.g. haemochromatosis, obesity, occupational.
Epidemiology of Osteoarthritis
- The most common form of arthritis
- It is estimated that 8.75 million people aged 45 or older in the UK have sought treatment for osteoarthritis.
- F>M
- More prevalent with increasing age
RF for Osteoarthritis
- Age
- Female sex
- Raised BMI
- Joint injury or trauma
- Joint malalignment and congenital joint dysplasia
- Genetic factors (COL2A1 collagen type 2 gene) and family history
- Abnormal or excessive stress e.g. from exercise or particular occupations
Pathophysiology of Osteoarthritis
The pathology affects the whole unit of the synovial joint including the synovial fluid and adjacent bone.
Osteoarthritis is classes as a non-inflammatory arthritis, however inflammatory mediators and processes do play a key role in the pathogenesis. It appears inflammatory cytokines interrupt normal repair of cartilage damage.
As cartilage is lost, the joint space narrows, with areas of highest load affected the most. Bone on bone interaction may occur causing large amounts of stress and reactive changes with subchondral sclerosis (via a process called eburnation) seen on x-ray. Cystic degeneration may occur resulting in subchondral cysts.
Essentially, cartillage is lost and chondroblasts are unable to replace and repair the lost cartillage, this leads to abnormal bone repair.
Mechanisms:
- Metalloproteinases secreted by chondrocytes degrade the collagen and proteoglycan
- Interleukin 1 (IL-1) and tumour necrosis factor-alpha (TNF-alpha) stimulate metalloproteinase production and inhibit collagen production
- Deficiency of growth factors such as insulin-like growth factor and transforming growth factor impairs matrix repair
- Gene susceptibly (35-60% influence) from multiple genes rather than a single gene defect - mutations in the gene for type II collagen have been associated with early polyarticular OA
Most affected areas:
- Knees
- Hips
- Sarco-ileac joints
- Cervical spine
- Wrist
- Carpometacarpal (base of thumb)
- Interphalangeal (finger joints)
Signs of Osteoarthritis
- Heberden’s nodes: swelling in distal interphalangeal joint (top finger joint)
- Bouchard’s nodes: swelling in proximal interphalangeal joint (middle finger joint)
- Fixed flexion deformity of carpometacarpal (base of thumb)
- Mucoid cysts: painful cyts found on dorsum of finger
Symptoms of Osteoarthritis
- Joint pain which is worse with activity
- Mechanical locking
- Giving way
- Joint tenderness
- Joint effusion (fluid in or around joint)
- Limited joint movement - stiffness
- Crepitus - crunching sensation when moving joint
Diagnostic criteria for Osteoarthritis
Investigations not always needed if there is a typical presentation:
- Over 45 years of age
- Typical activity related pain
- No morning stiffness (or morning stiffness <30 minutes)
1st line imaging for Osteoarthritis
- X-ray can be used to check severity and confirm diagnosis (mnemonic LOSS)
- Loss of joint space
- Osteophytes (bits of bone sicking out - bony overgrowth)
- Subarticular sclerosis (end of bone at point of articulation is thickened)
- Subchondral cysts (cysts appearing around the articulation)
Other investigations for Osteoarthritis
- MRI - good for knee imaging
- CT
- Ultrasound - can be used to exclude differentials or guide intervention e.g. steroid injections
- Aspiration of synovial fluid if there is a painful effusion - this shows viscous fluid with few leucocytes
- CRP may be slightly elevated
Differentials for Osteoarthritis
- Rheumatoid arthritis
- Chronic tophaceous gout
- Psoriatic arthritis
Non-pharmacological management of Osteoarthritis
- Patient education
- Weight loss
- Low impact exercise
- Heat and cold packs at site of pain
- Physiotherapy
- Occupational therapy
- Orthotics - helps with foot issues
Pharmacological management of Osteoarthritis
- 1st line - oral paracetamol + topical NSAIDs + topical capsaicin
- Oral NSAIDs + proton pump inhibitos (to protect the stomach from NSAID use)
- Opiates (e.g. codeine, morphine) - do not work for chronic pain, have many side effects and other issues associated with dependence and withdrawal.
Other management for Osteoarthritis
- Intra-articular steroid injection
- Joint replacement (arthroplasty) e.g. hip and knee
- Arthroscopy - only done if there are loose bodies causing knee lock
Prognosis for Osteoarthritis
OA is a chronic slowly progressive disease and is common with advancing age.
A combination of different modalities of treatment can provide adequate pain control and preserve function and quality of life for many patients. Despite treatment, most patients continue to have some degree of pain and functional limitation affecting their desired activities and quality of life.
Define Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease. This leads to a deforming, symmetrical inflammatory arthritis of the small joints which progresses to involve larger joints and other organs of the body, e.g. skin and lungs.
Epidemiology of RA
- The prevalence of RA is estimated to be 1% in the UK and it is the most common inflammatory arthritis.
- Prevalence is high in smokers
- Age: the peak age of onset is between 5th and 6th decade of life
- Female gender: 2-4x more common in women
Aetiology of RA
Interplay between genetics and environment, leading to immune response against self-antigens, especially citrullinated peptides.
Genetics
- HLA-DR1 and DR4are crucial in activating T-cells
- A number of other genes have been implicated, such as PTPN22, which is involved in T-cell activation
Environment
- Smoking
- Other pathogens e.g. bacteria
RF for RA
- Female gender
- Smoking
- Family history
- Infections
- Hormones: increased risk post-menopause, potentially due to a reduction in oestrogen levels
Pathophysiology of RA
Environmental triggers cause modification of self-antigens e.g. citrullination (arginine is converted to citrulline) of type II collagen and vimentin. Due to susceptibility genes (HLA-DR1 and -DR4) the immune cells cannot differentiate between self and non-self. Antigens are picked up by antigen presenting cells and carried to the lymph nodes, where T cells and B cells are activated. Autoantibodies are produced.
The T-cells and antibodies enter the circulation and reach the joints. Here, the T cells secrete cytokines (e.g. Interferon-gamma and IL-17) to recruit macrophages. Macrophages also produce cytokines (TNF, IL-1 and IL-6) which causes synovial cells to proliferate. This creates a pannus (thick synovial membrane made of fibroblasts, myofibroblasts and inflammatory cells). This can damage the cartilage, soft tissue and bones. Inflammatory cytokines also cause T-cells to express RANKL which can bind to osteoclasts, causing breakdown of bone.
Antibodies also enter the joint space:
- Rhematoid factor - IgM antibody that targets altered IgG
- Anti-CCP - targets cirtrullinated proteins. This forms an immune complex which can accumulate and activate complement system, promoting joint inflammation and injury. Chronic inflammation can also cause angiogensis, allowing more inflammatory cells to arrive.
Inflammatory cytokines can also escape the joint space and affect multiple organ systems e.g. causing fever in brain, rheumatoid nodules in skin, protein breakdown in muscle, inflamed blood vessels, fibroblasts and pleural effusion in lungs
Signs of RA
Can be articular or extra-articular (extra-articular outlined in complications section)
- Signs
-
Symmetrical polyarthritis: (on both sides of body)
- Swollen, warm and tender small joints of the hands and feet (MCP, PIP, MTP)
- Progresses to larger joints (shoulder, elbow, knee, ankle)
- Boutonniere deformity: PIP flexion and DIP hyperextension
- Swan-neck deformity: PIP hyperextension and DIP flexion
- Z-thumb deformity: hyperextension of the thumb IP joint with flexion of the MCP joint.
- Ulnar deviation of the fingers
- Popliteal cyst: synovial sac bulges posteriorly to the knee
- Rheumatoid nodules - lumps that can appear under skin and other areas e.g. lungs, hearts, eye
-
Symmetrical polyarthritis: (on both sides of body)
Symptoms of RA
- Morning stiffness: > 30 mins and improves throughout the day
- Malaise
- Myalgia
- Low-grade fever
Primary investigations for RA
- Primary investigations
- ESR and CRP:raised markers of inflammation
-
Rheumatoid factor (RF):present in 70% of patients
- RF is an IgM against the Fc portion of IgG
- Low specificity and can be raised in other autoimmune diseases e.g. Sjogren’s disease
- Absence of RF does not exclude RA
-
Anti-cyclic citrullinated peptide (anti-CCP):present in 80% of patients
- May be detected 15 years prior to symptom onset
- Similar sensitivity to RF but higher specificity (>90%)
- Titres can predict therapeutic response to rituximab and anti-TNFα agents
-
Joint X-rays:X-rays of the affected joints can aid diagnosis
- Soft-tissue swelling
- Periarticular osteoporosis
- Joint space narrowing
- Bony erosions
- Subluxation - incomplete or partial dislocation of a joint
Other investigations for RA
US and MRI - can help identify synovitis and have greater sensitivity in detecting bone erosions than x-ray
Differentials for RA
- Psoriatic arthritis
- Infectious arthritis
- Gout
- SLE
- Osteoarthritis